Positive Surgical Margins Rate and EGFR Family Members Expression in Prostate Cancer Treated With Bicalutamide
PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment
119
Participants
Timeline
Start Date
Not specified
Conditions
Prostate Cancer
Interventions
DRUG
Bicalutamide
Trial Locations (1)
67100
University of L'Aquila, L’Aquila
All Listed Sponsors
lead
University of L'Aquila
OTHER
NCT00421694 - Positive Surgical Margins Rate and EGFR Family Members Expression in Prostate Cancer Treated With Bicalutamide | Biotech Hunter | Biotech Hunter